Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Central motor conduction time.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
Vision and vision-related outcome measures in multiple sclerosis.
Diffuse astrocytoma arising within a demyelinating plaque.
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
Exome and regulatory element sequencing of neuromyelitis optica patients.
Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.
Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.
Cerebrospinal fluid analysis in infectious diseases of the nervous system: when to ask, what to ask, what to expect.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission.
Multiple sclerosis and cancer: When two wrongs make a right?
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
MS Trust critical of guidance on multiple sclerosis.
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Accuracy and reaction time in recognition of facial emotions in people with multiple sclerosis.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Diversity Matters: A Revised Guide to Myelination.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
Pages
« first
‹ previous
…
566
567
568
569
570
571
572
573
574
…
next ›
last »